BARCLAYS BANK PLC (GBUG)
FUBOTV INC. (FUBO)
Aptevo Therapeutics Inc. (APVO)
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
SCIENTURE HOLDINGS, INC. (SCNX)
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
STEPSTONE GROUP INC. (STEP)
StepStone Group and PitchBook Announce Partnership to Deliver Deal-Level Performance & Operating Metrics to Private Market Participants
MORGAN STANLEY (MS)
KARAT PACKAGING INC. (KRT)
Novavax Inc (NVAX)
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
PEAKSTONE REALTY TRUST (PKST)
BARCLAYS BANK PLC (GBUG)
EPAM Systems Inc. (EPAM)
EPAM Systems, Inc. - EPAM & Anthropic Team Up to Build the Future of Enterprise Transformation with Safe, Applied AI
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. - Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI®(taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer
Halozyme Therapeutics Inc (HALO)
Halozyme - Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™Technology